|
|
||||||||
Review |
Institute of Cellular and Molecular Science, Barts and the London, Queen Marys School of Medicine and Dentistry, University of London, London, UK
1 EMBL Heidelberg, Meyerhofstrasse 1, D-69117 Heidelberg, Germany
2 Stratagene Europe, PO Box 12085, 1100 AB Amsterdam, The Netherlands
3 Abteilung Physiologie, Zentralinstitut für Ernährungs und Lebensmittelforschung, Technische Universität München, Weihenstephaner Berg 3, D-85354 Freising-Weihenstephan, Germany
(Requests for offprints should be addressed to S A Bustin, Centre for Academic Surgery, 4th Floor Alexander Wing, Royal London Hospital, London E1 1BB, UK; Email: s.a.bustin{at}qmul.ac.uk)
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
It would be reasonable to presume that such widespread penetration is the result of an established and standardised technology. However, this is not so and many limitations of this assay are the same as those recorded for conventional endpoint RT-PCR (Bustin 2002). Furthermore, some of these problems have been exacerbated by the quantitative aspirations of this technology, not least due to the intimate association between quantification and amplification efficiency (Pfaffl 2001, Pfaffl et al. 2002). Worryingly, the extent of the unreliability of quantitative RT-PCR data, and its effect on their biological validity, is still not widely appreciated or acknowledged. One example is the threshold cycle (Ct), which records the cycle when sample fluorescence exceeds a chosen threshold above background fluorescence. The Ct is used for quantifying target copy number, yet its value is entirely subjective, as the threshold can be altered at will (Bustin & Nolan 2004). This brief perspective deals with the RT and data normalisation steps, two fundamental issues in need of urgent consideration. Their unpredictability constitutes a serious obstacle to the usefulness of this assay as an accurate and meaningful description of real-life mRNA levels. Other examples are exhaustively described elsewhere (Bustin 2004).
| Reverse Transcription |
|---|
|
|
|---|
Approximately 30% of cDNA priming in real-time RT-PCR assays is carried out using random primers. This approach primes the RT at multiple origins along every RNA template, hence produces more than one cDNA target per original mRNA target. Furthermore, the majority of cDNA synthesised from total RNA is ribosomal RNA (rRNA)-derived. This could create problems if the mRNA target of interest is present at low levels, as it may not be primed proportionately and its subsequent amplification may not be quantitative. Indeed, it has been demonstrated that random hexamers can overestimate mRNA copy numbers by up to 19-fold compared with a sequence-specific primer (Zhang & Byrne 1999). Another drawback is that a reaction primed by random primers is linear over a narrower range than a similar reaction primed by target-specific primers (Bustin & Nolan 2004). This has immediate consequences for the accuracy of quantification. Any correlation of this problem with specific RT remains to be determined, as does the difference between priming from total or mRNA, but for the moment it is not known how important an obstacle this constitutes to reliable and reproducible quantification.
Oligo-dT is used to prime approximately 40% of real-time RT-PCR assays. It is more specific than random priming, and is the best method to use when the aim is to obtain a faithful cDNA representation of the mRNA pool. It is also the most appropriate choice when aiming to amplify several target mRNAs from a limited RNA sample. However, as it requires full-length RNA it is not an effective choice for transcribing RNA that is likely to be fragmented, such as that typically obtained from archival material. Furthermore, the RT may fail to reach the upstream primer-binding site if secondary structures exist or if the primer-binding site is at the extreme 5'-end of a long mRNA. This may be the case if the target mRNA contains a very long untranslated 3'-region or if splice variants differ at the 5'-end of the mRNA (e.g. the MHC class II transactivator isoforms I, III and IV) (Sanderson et al. 2004). Approximately 10% of real-time RT-PCR assays use a combination of oligo-dT and random primers. However, while this may be acceptable for qualitative assays, this approach could exacerbate the problems inherent with the individual methods.
Target-specific primers are used in approximately 20% of RT-PCR assays. Their use results in the synthesis of the most specific cDNA and may provide the greatest sensitivity for quantitative assays (Lekanne Deprez et al. 2002). The main disadvantage of this method is that it requires separate priming reactions for each target; hence is not possible to return to the same preparation and amplify other targets at a later stage. It is also wasteful if only limited amounts of RNA are available. While it is possible to amplify more than one target in a single reaction tube (multiplex) (Wittwer et al. 2001), this is not trivial and requires careful experimental design and optimisation of reaction conditions if quantitative data are expected to be an accurate reflection of target mRNA levels.
Target abundance may also influence the choice of most appropriate primer for the RT step. For example, RT using specific primers may be appropriate for a very abundant target, but random priming may be better if the target is present at very low copy numbers.
Regardless of which method is used to prime cDNA synthesis, the PCR step requires target-specific primers. These are usually designed in isolation, using single templates of very limited genetic complexity. While the specificity of individual primers may be tested using BLAST, no further consideration may be given to the influence of non-target sites that can result in suboptimal binding of the primers. Accurate quantification requires primer sets that facilitate maximum amplification efficiency. In our experience, it is usually necessary to design, synthesise and validate several primer pairs, until a set is obtained that generates no primer dimers and results in near 100% amplification efficiency. Primers are best evaluated using SYBR Green-I chemistry and melting curve analysis. A recent report describes a useful algorithm for the identification of sequence-specific primers, which applies the highest filter stringency to residues at the 3'-end of the primer and to adventitious matches with abundant non-coding RNA (Wang & Seed 2003). These authors have also established a primer database containing >100 000 primers with uniform properties specifying most human and mouse genes. Not only would their general use simplify primer design for the individual researcher, but it would also initiate a process of standardisation, which is crucial for the generation of reproducible results.
In summary, each of the methods used to generate cDNA differ significantly with respect to specificity as well as cDNA yield and variety. Consequently, it is important to realise that RT-PCR results are comparable only when the same priming strategy and reaction conditions are used (Stahlberg et al. 2004a). In addition, it is not widely appreciated that random priming occurs whether or not primers are present and this can lead to a lowered and variable signal in the subsequent PCR assay (Frech & Peterhans 1994) (http://www.ambion.com/catalog/CatNum.php?1740).
| Normalisation |
|---|
|
|
|---|
Normalisation against high quality, accurately measured total RNA mass (Bustin 2002) has been shown to produce quantification results that are biologically relevant (Tricarico et al. 2002). This approach is crucially dependent on accurate quantification and quality assessment of the RNA. The opportune development of Agilents 2100 Bioanalyser and LabChip technology has provided a new standard of RNA quality control as well as permitting concomitant quantification of RNA. Similar in concept, but requiring an additional RT-PCR assay, is normalisation against one of the rRNAs (Bhatia et al. 1994, Zhong & Simons 1999). rRNA levels may vary less under conditions that affect the expression of mRNAs (Schmittgen & Zakrajsek 2000) and the use of rRNA has been claimed to be more reliable than that of several reference genes in rat livers (de Leeuw et al. 1989) and human skin fibroblasts (Mansur et al. 1993). A recent report comparing expression levels between activated and resting nucleated blood cells identified 18S rRNA as the most stable reference target. Furthermore, cytokine analysis revealed that only normalisation to 18S rRNA gave a result that satisfactorily reflected target gene mRNA expression levels per cell (Bas et al. 2004). However, normalisation against total RNA does not overcome the problem of variable subpopulations leading to inappropriate quantification and conclusions. Furthermore, total RNA levels may be elevated in highly proliferating cells and this will affect the accuracy of any comparison of copy numbers, for example between normal and tumour cells. In addition, it is not always possible to quantify total RNA, especially when dealing with very limited amounts of clinical samples. For normalisation against 18S RNA, concern has been expressed regarding rRNA transcription by a different RNA polymerase and possible imbalances in rRNA and mRNA fractions between different samples (Solanas et al. 2001). Furthermore, rRNA levels can be affected by biological factors and drugs (Spanakis 1993). Perhaps most importantly, the vast difference in abundance between all rRNA and most target mRNAs will result in different amplification kinetics that may generate misleading quantification data. A final drawback is that rRNA cannot be used for normalisation when quantifying targets from polyA-enriched samples.
In theory, the use of internal reference genes is the most appropriate solution for the normalisation problem. There is a constant stream of publications advocating the use of one or other individual reference genes, usually for more and more specialist application. However, invariably other reports contradict these findings and propose their own alternatives. There are numerous publications highlighting the fact that no single gene is able to fulfil the criteria required of a universal reference gene. All are regulated to some extent and none are constitutively expressed in all cell types and under all conditions independently of experimental design. Nevertheless, scrutiny of recently published papers quantifying cellular mRNA levels reveals that many continue to use single reference genes without demonstrating their appropriateness. The obvious alternative is to use multiple internal control genes. Different methods for identifying the most suitable combination of reference genes have been proposed. One ranks reference genes according to the similarity of their expression profile using a pair-wise comparison and uses their geometric mean as a normalisation factor (Vandesompele et al. 2002). The underlying assumption is that gene pairs showing stable expression patterns relative to each other are appropriate control genes. However, this model requires extensive practical validation to identify a combination of reference genes appropriate for individual experiment. Furthermore, it will top rank co-expressed genes. This drawback is addressed by another model that takes into consideration not just overall expression variation, but also systematic variation across sample subgroups (Andersen et al. 2004). These authors make the point that it does not matter whether a universal reference genes exists, as most experimental designs are restricted to a few tissue types or a few different histological stages of the same tissue. However, while this may be acceptable for comparisons between tissue culture cell lines or cloned rodent tissue, this underestimates the huge variability seen between individuals when analysing human tissues. This is borne out by their model identifying GAPDH as one of the most suitable reference genes in colorectal cancer, when there is considerable evidence that mRNA levels of this gene vary significantly between individuals and between paired normal and cancer tissue (Bustin et al. 1999, Bustin 2000, Tricarico et al. 2002). In any case, its gene product has a number of diverse activities unrelated to its glycolytic function (Sirover 1999). Other models addressing the most appropriate method for normalising results exist (Akilesh et al. 2003, Szabo et al. 2004), but are neither straightforward nor out-of-the-box solutions for general use. This variability emphasises the point that there are numerous ways of presenting data and that there is significant discordance between results obtained in different laboratories.
In summary, while appropriate normalisation is critical for obtaining biologically relevant results, the question of what constitutes appropriate normalisation remains to be answered in a satisfactory manner. Clearly, no one strategy is applicable to every experimental situation and it remains up to individual researchers to identify and validate the method most appropriate for their experimental conditions.
| Conclusion |
|---|
|
|
|---|
| Acknowledgements |
|---|
| References |
|---|
|
|
|---|
Andersen CL, Jensen JL & Orntoft TF 2004 Normalisation of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalisation, applied to bladder and colon cancer data sets. Cancer Research 64 52455250.
Bas A, Forsberg G, Hammarstrom S & Hammarstrom ML 2004 Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalisation in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes. Scandinavian Journal of Immunology 59 566573.[CrossRef][Web of Science][Medline]
Bhatia P, Taylor WR, Greenberg AH & Wright JA 1994 Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S-ribosomal RNA gene expression as RNA loading controls for northern blot analysis of cell lines of varying malignant potential. Analytical Biochemistry 216 223226.[CrossRef][Web of Science][Medline]
Bustin SA 2000 Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. Journal of Molecular Endocrinology 25 169193.[Abstract]
Bustin SA 2002 Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. Journal of Molecular Endocrinology 29 2339.[Abstract]
Bustin SA 2004 AZ of Quantitative PCR. San Diego, CA: IUL Press.
Bustin SA & Nolan T 2004 Pitfalls of quantitative reverse transcription polymerase chain reaction. Journal of Biomolecular Techniques 15 155166.[Medline]
Bustin SA, Gyselman VG, Williams NS & Dorudi S 1999 Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. British Journal of Cancer 79 18131820.[CrossRef][Web of Science][Medline]
Curry J, McHale C & Smith MT 2002 Low efficiency of the Moloney murine leukemia virus reverse transcriptase during reverse transcription of rare t(8;21) fusion gene transcripts. Biotechniques 32 768770.[Web of Science][Medline]
Deggerdal A & Larsen F 1997 Rapid isolation of PCR-ready DNA from blood, bone marrow and cultured cells, based on paramagnetic beads. Biotechniques 22 554557.[Web of Science][Medline]
de Leeuw WJ, Slagboom PE & Vijg J 1989 Quantitative comparison of mRNA levels in mammalian tissues: 28S ribosomal RNA level as an accurate internal control. Nucleic Acids Research 17 1013710138.
Fink L, Seeger W, Ermert L, Hanze J, Stahl U, Grimminger F, Kummer W & Bohle RM 1998 Real-time quantitative RT-PCR after laser-assisted cell picking. Nature Medicine 4 13291333.[CrossRef][Web of Science][Medline]
Frech B & Peterhans E 1994 RT-PCR: background priming during reverse transcription. Nucleic Acids Research 22 43424343.
Ginzinger DG 2002 Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Experimental Hematology 30 503512.[CrossRef][Web of Science][Medline]
Goidin D, Mamessier A, Staquet MJ, Schmitt D & Berthier-Vergnes O 2001 Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations. Analytical Biochemistry 295 1721.[CrossRef][Web of Science][Medline]
Karrer EE, Lincoln JE, Hogenhout S, Bennett AB, Bostoek RM, Martineau B, Lucas WJ, Gilchrist DG & Alexander D 1995 In situ isolation of mRNA from individual plant cells: creation of cell-specific cDNA libraries. PNAS 92 38143818.
Lekanne Deprez RH, Fijnvandraat AC, Ruijter JM & Moorman AF 2002 Sensitivity and accuracy of quantitative real-time polymerase chain reaction using SYBR green I depends on cDNA synthesis conditions. Analytical Biochemistry 307 6369.[CrossRef][Web of Science][Medline]
Mansur NR, Meyer-Siegler K, Wurzer JC & Sirover MA 1993 Cell cycle regulation of the glyceraldehyde-3-phosphate dehydrogenase/uracil DNA glycosylase gene in normal human cells. Nucleic Acids Research 21 993998.
Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29 E45.
Pfaffl MW, Horgan GW & Dempfle L 2002 Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Research 30 e36.
Raaijmakers MH, van Emst L, De Witte T, Mensink E & Raymakers RA 2002 Quantitative assessment of gene expression in highly purified hematopoietic cells using real-time reverse transcriptase polymerase chain reaction. Experimental Hematology 30 481487.[CrossRef][Web of Science][Medline]
Sanderson IR, Bustin SA, Dziennis S, Paraszczuk J & Stamm DS 2004 Age and diet act through distinct isoforms of the class II transactivator gene in mouse intestinal epithelium. Gastroenterology 127 203212.[CrossRef][Web of Science][Medline]
Schmittgen TD & Zakrajsek BA 2000 Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. Journal of Biochemical and Biophysical Methods 46 6981.[CrossRef][Web of Science][Medline]
Sirover MA 1999 New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochimica et Biophysica Acta 1432 159184.[CrossRef][Medline]
Smith RD, Brown B, Ikonomi P & Schechter AN 2003 Exogenous reference RNA for normalisation of real-time quantitative PCR. Biotechniques 34 8891.[Web of Science][Medline]
Solanas M, Moral R & Escrich E 2001 Unsuitability of using ribosomal RNA as loading control for Northern blot analyses related to the imbalance between messenger and ribosomal RNA content in rat mammary tumors. Analytical Biochemistry 288 99102.[CrossRef][Web of Science][Medline]
Spanakis E 1993 Problems related to the interpretation of autoradiographic data on gene expression using common constitutive transcripts as controls. Nucleic Acids Research 21 38093819.
Stahlberg A, Hakansson J, Xian X, Semb H & Kubista M 2004a Properties of the reverse transcription reaction in mRNA quantification. Clinical Chemistry 50 509515.
Stahlberg A, Kubista M & Pfaffl M 2004b Comparison of reverse transcriptases in gene expression analysis. Clinical Chemistry 50 16781680.
Szabo A, Perou CM, Karaca M, Perreard L, Quackenbush JF & Bernard PS 2004 Statistical modeling for selecting housekeeper genes. Genome Biology 5 R59.[CrossRef][Medline]
Thellin O, Zorzi W, Lakaye B, De Borman B, Coumans B, Hennen G, Grisar T, Igout A & Heinen E 1999 Housekeeping genes as internal standards: use and limits. Journal of Biotechnology 75 291295.[CrossRef][Web of Science][Medline]
Tricarico C, Pinzani P, Bianchi S, Paglierani M, Distante V, Pazzagli M, Busin SA & Orlando C 2002 Quantitative real-time reverse transcription polymerase chain reaction: normalisation to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Analytical Biochemistry 309 293300.[CrossRef][Web of Science][Medline]
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A & Speleman F 2002 Accurate normalisation of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 3 0034.10034.11.
Wang X & Seed B 2003 A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Research 31 e154.
Wittwer CT, Herrmann MG, Gundry CN & Elenitoba-Johnson KS 2001 Real-time multiplex PCR assays. Methods 25 430442.[CrossRef][Web of Science][Medline]
Zhang J & Byrne CD 1999 Differential priming of RNA templates during cDNA synthesis markedly affects both accuracy and reproducibility of quantitative competitive reverse-transcriptase PCR. Biochemical Journal 337 231241.
Zhong H & Simons JW 1999 Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochemical and Biophysical Research Communications 259 523526.[CrossRef][Web of Science][Medline]
Received 12 January 2005
Accepted 21 January 2005
This article has been cited by other articles:
![]() |
V. Moreau, E. Voirin, C. Paris, M. Kotera, M. Nothisen, J.-S. Remy, J.-P. Behr, P. Erbacher, and N. Lenne-Samuel Zip Nucleic Acids: new high affinity oligonucleotides as potent primers for PCR and reverse transcription Nucleic Acids Res., October 1, 2009; 37(19): e130 - e130. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Navarro, G. Marque, C. Ayax, G. Keller, J. P. Borges, C. Marque, and C. Teulieres Complementary regulation of four Eucalyptus CBF genes under various cold conditions J. Exp. Bot., July 1, 2009; 60(9): 2713 - 2724. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Bustin, V. Benes, J. A. Garson, J. Hellemans, J. Huggett, M. Kubista, R. Mueller, T. Nolan, M. W. Pfaffl, G. L. Shipley, et al. The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments Clin. Chem., April 1, 2009; 55(4): 611 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Liao, E. S. Vanzant, D. L. Harmon, K. R. McLeod, J. A. Boling, and J. C. Matthews Ruminal and abomasal starch hydrolysate infusions selectively decrease the expression of cationic amino acid transporter mRNA by small intestinal epithelia of forage-fed beef steers J Dairy Sci, March 1, 2009; 92(3): 1124 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guenin, M. Mauriat, J. Pelloux, O. Van Wuytswinkel, C. Bellini, and L. Gutierrez Normalization of qRT-PCR data: the necessity of adopting a systematic, experimental conditions-specific, validation of references J. Exp. Bot., February 1, 2009; 60(2): 487 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Srivastava, N. K. Ramaswamy, R. Mukopadhyaya, M. G. C. Jincy, and S. F. D'Souza Thiourea modulates the expression and activity profile of mtATPase under salinity stress in seeds of Brassica juncea Ann. Bot., February 1, 2009; 103(3): 403 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yue, T. A. Ponzio, R. L. Fields, and H. Gainer Oxytocin and vasopressin gene expression and RNA splicing patterns in the rat supraoptic nucleus Physiol Genomics, November 12, 2008; 35(3): 231 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Coral, N. Angayarkanni, J. Madhavan, M. Bharathselvi, S. Ramakrishnan, K. Nandi, P. Rishi, N. Kasinathan, and S. Krishnakumar Lysyl Oxidase Activity in the Ocular Tissues and the Role of LOX in Proliferative Diabetic Retinopathy and Rhegmatogenous Retinal Detachment Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4746 - 4752. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. I. Daud and M. E. Scott Validation of Reference Genes in Cervical Cell Samples from Human Papillomavirus-Infected and -Uninfected Women for Quantitative Reverse Transcription-PCR Assays Clin. Vaccine Immunol., September 1, 2008; 15(9): 1369 - 1373. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ma, G. C. Horvath, M. K. Kistler, and W. S. Kistler Expression Patterns of SP1 and SP3 During Mouse Spermatogenesis: SP1 Down-Regulation Correlates with Two Successive Promoter Changes and Translationally Compromised Transcripts Biol Reprod, August 1, 2008; 79(2): 289 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Lenz, K. S. Williamson, B. Pitts, P. S. Stewart, and M. J. Franklin Localized Gene Expression in Pseudomonas aeruginosa Biofilms Appl. Envir. Microbiol., July 15, 2008; 74(14): 4463 - 4471. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schonenbrucher, A. Abdulmawjood, K. Failing, and M. Bulte New Triplex Real-Time PCR Assay for Detection of Mycobacterium avium subsp. paratuberculosis in Bovine Feces Appl. Envir. Microbiol., May 1, 2008; 74(9): 2751 - 2758. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Grundemann, F. Schlaudraff, O. Haeckel, and B. Liss Elevated {alpha}-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease Nucleic Acids Res., April 1, 2008; 36(7): e38 - e38. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Liao, M. J. Alman, E. S. Vanzant, E. D. Miles, D. L. Harmon, K. R. McLeod, J. A. Boling, and J. C. Matthews Basal Expression of Nucleoside Transporter mRNA Differs Among Small Intestinal Epithelia of Beef Steers and Is Differentially Altered by Ruminal or Abomasal Infusion of Starch Hydrolysate J Dairy Sci, April 1, 2008; 91(4): 1570 - 1584. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Morganstein, M. Christian, J. J. O. Turner, M. G. Parker, and R. White Conditionally immortalized white preadipocytes: a novel adipocyte model J. Lipid Res., March 1, 2008; 49(3): 679 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Liao, E. S. Vanzant, J. A. Boling, and J. C. Matthews Identification and expression pattern of cationic amino acid transporter-1 mRNA in small intestinal epithelia of Angus steers at four production stages J Anim Sci, March 1, 2008; 86(3): 620 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jayasundara, D. W. Towle, D. Weihrauch, and C. Spanings-Pierrot Gill-specific transcriptional regulation of Na+/K+-ATPase {alpha}-subunit in the euryhaline shore crab Pachygrapsus marmoratus: sequence variants and promoter structure J. Exp. Biol., June 15, 2007; 210(12): 2070 - 2081. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Capparelli, F. Alfano, M. G. Amoroso, G. Borriello, D. Fenizia, A. Bianco, S. Roperto, F. Roperto, and D. Iannelli Protective Effect of the Nramp1 BB Genotype against Brucella abortus in the Water Buffalo (Bubalus bubalis) Infect. Immun., February 1, 2007; 75(2): 988 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Warren, D. Bryder, I. L. Weissman, and S. R. Quake Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR PNAS, November 21, 2006; 103(47): 17807 - 17812. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Varsamos, B. Xuereb, T. Commes, G. Flik, and C. Spanings-Pierrot Pituitary hormone mRNA expression in European sea bass Dicentrarchus labrax in seawater and following acclimation to fresh water. J. Endocrinol., November 1, 2006; 191(2): 473 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Ketelaere, K. Goossens, L. Peelman, and C. Burvenich Technical note: validation of internal control genes for gene expression analysis in bovine polymorphonuclear leukocytes. J Dairy Sci, October 1, 2006; 89(10): 4066 - 4069. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schulz, T. Hyslop, J. Haaf, C. Bonaccorso, K. Nielsen, M. E. Witek, R. Birbe, J. Palazzo, D. Weinberg, and S. A. Waldman A Validated Quantitative Assay to Detect Occult Micrometastases by Reverse Transcriptase-Polymerase Chain Reaction of Guanylyl Cyclase C in Patients with Colorectal Cancer Clin. Cancer Res., August 1, 2006; 12(15): 4545 - 4552. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zheng, Y. Luo, and G. K. McMaster Sensitive and Quantitative Measurement of Gene Expression Directly from a Small Amount of Whole Blood Clin. Chem., July 1, 2006; 52(7): 1294 - 1302. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |